H49.43

Clinical Causes: Genetic mutations, often inherited in a mitochondrial pattern, affecting the energy production in muscles. Mitochondrial DNA disorders that impair the function of the energy-producing structures within cells. Rarely, it may be associated with other neurological or mitochondrial syndromes.

Key Symptoms: Gradual weakness or paralysis of eye muscles, leading to limited eye movement in various directions. Drooping eyelids (ptosis) that can affect one or both eyes. Difficulty coordinating eye movements, resulting in problems with tracking moving objects. Double vision (diplopia) due to misalignment of the eyes. Potential facial muscle weakness and other neurological signs depending on severity and progression.

Diagnosis Path: Diagnosis typically involves a detailed medical history review and physical examination focused on eye movements. Additional tests may include: - **Electromyography (EMG):** To assess electrical activity of eye muscles. - **Genetic testing:** To identify specific mitochondrial gene mutations. - **Imaging studies:** MRI scans of the brain and orbits to exclude other causes. - **Blood tests:** To evaluate mitochondrial function and rule out other metabolic disorders.

Treatment Protocols: There is currently no cure for progressive external ophthalmoplegia. Management focuses on alleviating symptoms and improving quality of life, and may include: - **Prism glasses:** To help correct double vision. - **Surgical procedures:** To address eyelid drooping or eye muscle alignment issues. - **Supportive therapies:** Such as physical therapy to maintain muscle strength and function. - **Regular monitoring:** To assess progression and adapt treatment plans accordingly. Researchers continue to study mitochondrial disorders to develop potential therapies, but treatment remains primarily symptomatic.